Company · CIK 0001113148 · SIC 2834 — Pharmaceutical Preparations
INFINITY PHARMACEUTICALS, INC. · INFI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2018 PForm 4 → | Dec 17, 7:40 pm EST | BVF PARTNERS L P/IL +610% Owner | 175,000 | $1.20 | $209,913 | 6,631,136 | +2.71% | plan? |
| Nov 28, 2018 PForm 4 → | Nov 30, 6:28 pm EST | BVF PARTNERS L P/IL +610% Owner | 100,000 | $1.30 | $130,000 | 6,510,597 | +1.56% | plan? |
| Nov 19, 2018 PForm 4 → | Nov 21, 5:57 pm EST | BVF PARTNERS L P/IL +610% Owner | 1,469,826 | $1.37 | $2,011,421 | 1,254,993 | — | plan? |
| Nov 13, 2018 PForm 4 → | Nov 15, 8:07 pm EST | BVF PARTNERS L P/IL +610% Owner | 905,932 | $1.35 | $1,220,906 | 5,815,887 | +18.5% | plan? |
| Oct 1, 2018 SForm 4 → | Oct 2, 4:30 pm EDT | Adelene Q PerkinsChief Executive Officer, Director | 5,000 | $2.82 | $14,100 | 609,561 | −0.81% | plan? |
| Aug 15, 2018 SForm 4 → | Aug 17, 4:05 pm EDT | Jeffery KutokChief Scientific Officer | 14,313 | $2.00 | $28,687 | 0 | −100% | plan? |
| Jun 22, 2018 SForm 4 → | Jun 25, 5:00 pm EDT | Jeffery KutokChief Scientific Officer | 14,313 | $2.00 | $28,695 | 14,313 | −50.0% | plan? |
| Jun 19, 2018 PForm 4 → | Jun 21, 6:57 pm EDT | BVF PARTNERS L P/IL +610% Owner | 3,942,091 | $1.65 | $6,504,450 | 1,167,191 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:35 am EDT | Jeffrey BerkowitzDirector | 22,857 | $1.75 | $40,000 | 58,988 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:34 am EDT | Ian F SmithDirector | 22,857 | $1.75 | $40,000 | 45,845 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:33 am EDT | Anthony B EvninDirector | 11,428 | $1.75 | $19,999 | 130,013 | — | plan? |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:30 am EDT | David W BeierDirector | 5,714 | $1.75 | $10,000 | 5,714 | — | plan? |
| Apr 9, 2018 PForm 4 → | Apr 11, 6:01 pm EDT | BVF PARTNERS L P/IL +610% Owner | 1,510,000 | $1.97 | $2,970,000 | 950,473 | — | plan? |
| Mar 5, 2018 SForm 4 → | Mar 7, 4:22 pm EST | Adelene Q PerkinsChief Executive Officer, Director | 5,000 | $2.78 | $13,890 | 607,252 | −0.82% | plan? |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:07 pm EST | Seth A TaskerGeneral Counsel | 22,351 | — | — | 41,284 | — | plan? |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:06 pm EST | Adelene Q PerkinsChief Executive Officer, Director | 69,924 | — | — | 612,252 | — | plan? |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:05 pm EST | Jeffery KutokChief Scientific Officer | 28,626 | — | — | 28,626 | — | plan? |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:05 pm EST | Lawrence E BlochPresident | 37,881 | — | — | 626,133 | — | plan? |
| Dec 6, 2017 PForm 4 → | Dec 7, 9:11 am EST | Lawrence E BlochPresident | 500,000 | $1.81 | $905,000 | 580,944 | +618% | plan? |
| Oct 3, 2017 PForm 4 → | Oct 5, 8:07 pm EDT | BVF PARTNERS L P/IL +610% Owner | 1,600,046 | $1.26 | $2,008,076 | 790,583 | — | plan? |
| Jul 21, 2017 AForm 4 → | Jul 24, 5:48 pm EDT | Adelene Q PerkinsChief Executive Officer, Director | 85,800 | — | — | 535,020 | — | plan? |
| Jul 21, 2017 AForm 4 → | Jul 24, 5:41 pm EDT | Lawrence E BlochPresident | 39,039 | — | — | 80,944 | — | plan? |
| Jul 21, 2017 AForm 4 → | Jul 24, 5:41 pm EDT | Seth A TaskerGeneral Counsel | 8,916 | — | — | 17,833 | — | plan? |
| May 25, 2017 AForm 4 → | May 26, 8:28 am EDT | Jeffrey BerkowitzDirector | 5,747 | $1.74 | $10,000 | 36,131 | — | plan? |
| May 25, 2017 AForm 4 → | May 26, 8:26 am EDT | Anthony B EvninDirector | 11,494 | $1.74 | $20,000 | 118,585 | — | plan? |
| May 25, 2017 AForm 4 → | May 26, 8:23 am EDT | Ian F SmithDirector | 22,988 | $1.74 | $39,999 | 22,988 | — | plan? |
| Mar 17, 2017 SForm 4 → | Mar 20, 4:10 pm EDT | Michael C VenutiDirector | 6,250 | $3.48 | $21,750 | 50,000 | −11.1% | plan? |
| Jan 3, 2017 PForm 4 → | Jan 5, 5:30 pm EST | BVF PARTNERS L P/IL +610% Owner | 4,379 | $1.34 | $5,867 | 2,339,083 | +0.19% | plan? |
| Dec 28, 2016 PForm 4 → | Dec 30, 5:37 pm EST | BVF PARTNERS L P/IL +610% Owner | 742,401 | $1.34 | $991,565 | 2,335,849 | +46.6% | plan? |
| Dec 16, 2016 PForm 4 → | Dec 20, 6:26 pm EST | BVF PARTNERS L P/IL +610% Owner | 654,921 | $1.31 | $855,491 | 621,547 | — | plan? |
| Dec 12, 2016 SForm 4 → | Dec 14, 5:16 pm EST | Sujay KangoChief Commercial Officer | 75,000 | $1.28 | $95,871 | 599 | −99.2% | plan? |
| Dec 1, 2016 PForm 4 → | Dec 2, 5:50 pm EST | BVF PARTNERS L P/IL +610% Owner | 201,394 | $1.19 | $238,845 | 550,470 | +57.7% | plan? |
| Oct 31, 2016 AForm 4/A → | Apr 14, 2017, 4:05 pm EDT | Adelene Q PerkinsChief Executive Officer, Director | 85,800 | — | — | 449,220 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 4:57 pm EDT | Seth A TaskerGeneral Counsel | 8,917 | — | — | 8,917 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 4:56 pm EDT | Lawrence E BlochEVP, CFO & CBO | 39,039 | — | — | 41,905 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 4:56 pm EDT | Sujay KangoChief Commercial Officer | 75,000 | — | — | 75,599 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 4:56 pm EDT | Julian AdamsPresident of R&D | 59,150 | — | — | 59,150 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 4:55 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 85,800 | — | — | 447,411 | — | plan? amended |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:53 pm EDT | Anthony B EvninDirector | 13,157 | $1.52 | $19,999 | 107,091 | — | plan? |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:53 pm EDT | Eric S LanderDirector | 6,578 | $1.52 | $9,999 | 80,319 | — | plan? |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:52 pm EDT | Jeffrey BerkowitzDirector | 26,315 | $1.52 | $39,999 | 30,384 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 4:17 pm EDT | Eric S LanderDirector | 2,034 | $8.60 | $17,492 | 73,741 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 4:16 pm EDT | Anthony B EvninDirector | 2,034 | $8.60 | $17,492 | 93,934 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 4:15 pm EDT | Jeffrey BerkowitzDirector | 4,069 | $8.60 | $34,993 | 4,069 | — | plan? |
| Jun 25, 2015 SForm 4 → | Jun 26, 4:15 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 5,000 | $10.93 | $54,650 | 359,432 | −1.37% | plan? |
| Jun 15, 2015 SForm 4 → | Jun 16, 4:15 pm EDT | Vito J. PalombellaChief Scientific Officer | 4,737 | $10.97 | $51,965 | 868 | −84.5% | plan? |
| May 27, 2015 SForm 4 → | May 28, 4:16 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 10,000 | $12.81 | $128,100 | 364,432 | −2.67% | plan? |
| May 14, 2015 SForm 4 → | May 15, 4:28 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 10,000 | $12.18 | $121,800 | 374,432 | −2.60% | plan? |
| Apr 30, 2015 MForm 4 → | May 1, 4:42 pm EDT | Vito J. PalombellaChief Scientific Officer | 4,737 | $2.04 | $9,663 | 5,605 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 17, 5:40 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 20,000 | $16.00 | $320,000 | 384,432 | −4.95% | plan? |
| Mar 5, 2015 SForm 4 → | Mar 9, 5:36 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 25,000 | $16.50 | $412,500 | 404,432 | −5.82% | plan? |
| Jan 29, 2015 SForm 4/A → | Mar 9, 5:34 pm EDT | Adelene Q PerkinsPresident & CEO, Director | 20,000 | $14.83 | $296,536 | 429,432 | −4.45% | plan? |
| Jan 29, 2015 SForm 4 → | Feb 2, 4:15 pm EST | Adelene Q PerkinsPresident & CEO, Director | 20,000 | $14.83 | $296,536 | 427,535 | −4.47% | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2019 AForm 4 → | Jan 7, 4:07 pm EST | Seth A TaskerGeneral Counsel | 140,000 | — | — | 140,000 | — | |
| Jan 4, 2019 AForm 4 → | Jan 7, 4:06 pm EST | Lawrence E BlochPresident | 335,000 | — | — | 335,000 | — | |
| Jan 4, 2019 AForm 4 → | Jan 7, 4:05 pm EST | Jeffery KutokChief Scientific Officer | 155,000 | — | — | 155,000 | — | |
| Jan 4, 2019 AForm 4 → | Jan 7, 4:05 pm EST | Samuel AgrestaChief Medical Officer | 62,596 | — | — | 62,596 | — | |
| Jan 4, 2019 AForm 4 → | Jan 7, 4:05 pm EST | Adelene Q PerkinsChief Executive Officer, Director | 243,000 | — | — | 243,000 | — | |
| Aug 6, 2018 AForm 4 → | Aug 7, 5:10 pm EDT | Samuel AgrestaChief Medical Officer | 300,000 | — | — | 300,000 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:37 am EDT | Norman C SelbyDirector | 32,000 | — | — | 2,000 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:35 am EDT | Jeffrey BerkowitzDirector | 20,000 | — | — | 20,000 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:34 am EDT | Ian F SmithDirector | 24,000 | — | — | 4,000 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:33 am EDT | Anthony B EvninDirector | 22,000 | — | — | 2,000 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:32 am EDT | Michael KauffmanDirector | 20,000 | — | — | 20,000 | — | |
| Jun 12, 2018 AForm 4 → | Jun 14, 8:31 am EDT | Michael C VenutiDirector | 24,000 | — | — | 4,000 | — | |
| Apr 1, 2018 AForm 4 → | Apr 2, 8:22 pm EDT | David W BeierDirector | 40,000 | — | — | 40,000 | — | |
| Jan 8, 2018 AForm 4 → | Jan 9, 4:10 pm EST | Adelene Q PerkinsChief Executive Officer, Director | 500,000 | — | — | 500,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:07 pm EST | Seth A TaskerGeneral Counsel | 65,000 | — | — | 65,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:06 pm EST | Adelene Q PerkinsChief Executive Officer, Director | 180,000 | — | — | 180,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:05 pm EST | Jeffery KutokChief Scientific Officer | 70,000 | — | — | 70,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:05 pm EST | Lawrence E BlochPresident | 100,000 | — | — | 100,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:31 am EDT | Norman C SelbyDirector | 32,000 | — | — | 2,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:29 am EDT | Lawrence E BlochPresident | 250,000 | — | — | 250,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:28 am EDT | Jeffrey BerkowitzDirector | 20,000 | — | — | 20,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:26 am EDT | Anthony B EvninDirector | 22,000 | — | — | 2,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:23 am EDT | Ian F SmithDirector | 24,000 | — | — | 4,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:21 am EDT | Jeffery KutokChief Scientific Officer | 125,000 | — | — | 125,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:19 am EDT | Michael C VenutiDirector | 24,000 | — | — | 4,000 | — | |
| May 25, 2017 AForm 4 → | May 26, 8:16 am EDT | Seth A TaskerGeneral Counsel | 150,000 | — | — | 150,000 | — | |
| Apr 5, 2017 AForm 4 → | Apr 6, 8:27 am EDT | Michael KauffmanDirector | 40,000 | — | — | 40,000 | — | |
| Feb 10, 2017 AForm 4 → | Feb 14, 5:48 pm EST | Jeffery KutokChief Scientific Officer | 250,000 | — | — | 250,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:59 pm EST | Michael C VenutiDirector | 40,000 | — | — | 40,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:55 pm EST | Anthony B EvninDirector | 40,000 | — | — | 40,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:52 pm EST | Ian F SmithDirector | 40,000 | — | — | 40,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:51 pm EST | Norman C SelbyDirector | 40,000 | — | — | 40,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:47 pm EST | Adelene Q PerkinsChief Executive Officer, Director | 1,000,000 | — | — | 1,000,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:47 pm EST | Jose BaselgaDirector | 40,000 | — | — | 40,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:43 pm EST | Lawrence E BlochPresident | 500,000 | — | — | 500,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:41 pm EST | Seth A TaskerGeneral Counsel | 250,000 | — | — | 250,000 | — | |
| Jan 6, 2017 AForm 4 → | Jan 9, 4:40 pm EST | Jeffrey BerkowitzDirector | 40,000 | — | — | 40,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:17 pm EDT | Jose BaselgaDirector | 20,000 | — | — | 20,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:15 pm EDT | Norman C SelbyDirector | 32,000 | — | — | 2,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:58 pm EDT | Ian F SmithDirector | 24,000 | — | — | 4,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:53 pm EDT | Anthony B EvninDirector | 22,000 | — | — | 2,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:53 pm EDT | Michael C VenutiDirector | 24,000 | — | — | 4,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:53 pm EDT | Eric S LanderDirector | 20,000 | — | — | 20,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 5:52 pm EDT | Jeffrey BerkowitzDirector | 20,000 | — | — | 20,000 | — | |
| May 2, 2016 AForm 4 → | May 4, 4:22 pm EDT | Christopher M LindblomPrincipal Accounting Officer | 40,000 | — | — | 40,000 | — | |
| Jan 6, 2016 AForm 4 → | Jan 8, 4:06 pm EST | Lawrence E BlochEVP, CFO & CBO | 70,000 | — | — | 70,000 | — | |
| Jan 6, 2016 AForm 4 → | Jan 8, 4:05 pm EST | Sujay KangoChief Commercial Officer | 60,000 | — | — | 60,000 | — | |
| Jan 6, 2016 AForm 4 → | Jan 8, 4:05 pm EST | Julian AdamsPresident of R&D | 80,000 | — | — | 80,000 | — | |
| Jan 6, 2016 AForm 4 → | Jan 8, 4:05 pm EST | Adelene Q PerkinsPresident & CEO, Director | 185,000 | — | — | 185,000 | — | |
| Oct 19, 2015 AForm 4 → | Oct 21, 4:18 pm EDT | William C Bertrand Jr.General Counsel | 200,000 | — | — | 200,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:59 pm EDT | Norman C SelbyDirector | 27,000 | — | — | 2,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:40 pm EDT | Jose BaselgaDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:36 pm EDT | Ian F SmithDirector | 19,000 | — | — | 4,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:33 pm EDT | Gwen A. FyfeDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:33 pm EDT | Eric S LanderDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:28 pm EDT | Jeffrey BerkowitzDirector | 15,000 | — | — | 15,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:28 pm EDT | Anthony B EvninDirector | 17,000 | — | — | 2,000 | — | |
| Jun 15, 2015 AForm 4 → | Jun 16, 4:25 pm EDT | Michael C VenutiDirector | 19,000 | — | — | 4,000 | — | |
| Apr 30, 2015 MForm 4 → | May 1, 4:42 pm EDT | Vito J. PalombellaChief Scientific Officer | 4,737 | — | — | 0 | — | |
| Apr 15, 2015 AForm 4 → | Apr 15, 6:04 pm EDT | Winston K.C. LamGeneral Counsel | 200,000 | — | — | 200,000 | — | |
| Mar 31, 2015 AForm 4 → | Apr 1, 6:16 pm EDT | Sujay KangoChief Commercial Officer | 200,000 | — | — | 200,000 | — | |
| Jan 14, 2015 AForm 4 → | Jan 16, 4:17 pm EST | Adelene Q PerkinsPresident & CEO, Director | 250,000 | — | — | 250,000 | — | |
| Jan 14, 2015 AForm 4 → | Jan 16, 4:16 pm EST | Lawrence E BlochEVP, CFO & CBO | 125,000 | — | — | 125,000 | — | |
| Jan 14, 2015 AForm 4 → | Jan 16, 4:16 pm EST | Vito J. PalombellaChief Scientific Officer | 85,000 | — | — | 85,000 | — | |
| Jan 14, 2015 AForm 4 → | Jan 16, 4:15 pm EST | Julian AdamsPresident of R&D | 125,000 | — | — | 125,000 | — | |
| Jan 14, 2015 AForm 4 → | Jan 16, 4:15 pm EST | David RothChief Medical Officer | 85,000 | — | — | 85,000 | — |